UNH's oversold status has been overly done, as the market digests the market-wide headwinds arising from regulatory changes ...

UnitedHealth Group (UNH) last week officially confirmed what Wall Street has suspected for months: The healthcare giant is ...

Healthcare stocks are typically seen as defensive plays, especially during market uncertainty, but even industry giants aren't immune to volatility. UnitedHealth Group (UNH), once considered a ...

UnitedHealth’s (NYSE: UNH) turbulent run in 2025 is escalating after the firm reported disappointing Q2 earnings results.

Truist, TD Cowen, Oppenheimer, Piper Sandler, BofA, and KeyBanc all lowered targets, with most firms keeping their ratings ...

With UnitedHealth’s weak Q2 results, the reset in 2025 guidance and earnings expectations brings clarity, but headwinds seem ...

UnitedHealth Group Incorporated (NYSE:UNH) is an American multinational healthcare and insurance company. The company is ...

UnitedHealth Group Inc (NYSE: UNH) has reinstated its full-year guidance, but the management’s estimates hardly brought any ...

The disclosure sent UNH shares tumbling 4.7%, reflecting investor unease with the ongoing troubles with the healthcare stock.

While we acknowledge the potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk ...

UNH stock fell 36.2% from a high of $305.31 on 19 February 2020 to $194.86 on 23 March 2020, in comparison to a peak-to-trough drop of 33.9% for the S&P 500 The stock fully recovered to its pre ...